Sphingotec’s biomarker penKid® predicts septic acute kidney injury
High penKid® plasma levels identified all ED patients with hidden AKI and AKI at admission and reflected worsening of kidney function. penKid® point-of-care (POC) implementation in EDs could eliminate current limitations of AKI prediction in septic patients allowing physicians to adjust treatment and therapy monitoring of patients with suspected AKI. An automated CE-marked…
Details